Current use of stereotactic body radiation therapy for low and intermediate risk prostate cancer: A National Cancer Database Analysis.

Timothy D MalouffWilliam C StrossDanushka S SeneviratneMark R WaddleByron C MaySteven J BuskirkKatherine S Tzou

Published in: Prostate cancer and prostatic diseases (2019)

The use of SBRT for low and intermediate risk prostate cancer has increased significantly from 2004 to 2015, coinciding with recently published data supporting the efficacy and favorable toxicity profile of this technique.

Keyphrases

prostate cancer
radical prostatectomy
oxidative stress
electronic health record
emergency department
machine learning
big data
adverse drug
deep learning
breast cancer risk